Your browser doesn't support javascript.
loading
Timing and outcomes of second-line therapy in the era of daratumumab-based frontline therapy in AL amyloidosis.
Bazarbachi, Abdul-Hamid; Bhutani, Divaya; Radhakrishnan, Jai; Mapara, Markus; Maurer, Mathew S; Lentzsch, Suzanne; Chakraborty, Rajshekhar.
Afiliação
  • Bazarbachi AH; Division of Hematology/Oncology, Columbia University Irving Medical Center/New York-Presbyterian Hospital, New York, New York, USA.
  • Bhutani D; Division of Hematology/Oncology, Columbia University Irving Medical Center/New York-Presbyterian Hospital, New York, New York, USA.
  • Radhakrishnan J; Division of Nephrology, Columbia University Irving Medical Center/New York-Presbyterian Hospital, New York, New York, USA.
  • Mapara M; Division of Hematology/Oncology, Columbia University Irving Medical Center/New York-Presbyterian Hospital, New York, New York, USA.
  • Maurer MS; Division of Cardiology, Columbia University Irving Medical Center/New York-Presbyterian Hospital, New York, New York, USA.
  • Lentzsch S; Division of Hematology/Oncology, Columbia University Irving Medical Center/New York-Presbyterian Hospital, New York, New York, USA.
  • Chakraborty R; Division of Hematology/Oncology, Columbia University Irving Medical Center/New York-Presbyterian Hospital, New York, New York, USA.
Am J Hematol ; 99(11): 2225-2228, 2024 Nov.
Article em En | MEDLINE | ID: mdl-39096115
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Amiloidose de Cadeia Leve de Imunoglobulina / Anticorpos Monoclonais Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Amiloidose de Cadeia Leve de Imunoglobulina / Anticorpos Monoclonais Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article